An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration
about
Insights into the channel gating of P2X receptors from structures, dynamics and small moleculesExtracellular adenosine 5'-triphosphate concentrations changes in rat spinal cord associated with the activation of urinary bladder afferents. A microdialysis studyPurinergic control of lysenin's transport and voltage-gating propertiesPurinergic receptors as potential therapeutic targets in Alzheimer's disease.A Molecular Model for Lithium's Bioactive Form.Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.Purinergic signaling and the functioning of the nervous system cells.Disruption of the ATP/adenosine balance in CD39-/- mice is associated with handling-induced seizures.P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells.Short- and long-term (trophic) purinergic signalling.Melatonin receptor deficiency decreases and temporally shifts ecto-5'-nucleotidase mRNA levels in mouse prosencephalon.Regulation of Pannexin 1 Surface Expression by Extracellular ATP: Potential Implications for Nervous System Function in Health and Disease.Nucleotide transmitters ATP and ADP mediate intercellular calcium wave communication via P2Y12/13 receptors among BV-2 microglia.Purinergic signalling in neuroregeneration.Purinergic Signalling: Therapeutic Developments.Astrocyte calcium waves propagate proximally by gap junction and distally by extracellular diffusion of ATP released from volume-regulated anion channels.Down-regulation of NTPDase2 and ADP-sensitive P2 Purinoceptors Correlate with Severity of Symptoms during Experimental Autoimmune Encephalomyelitis.Our (Mother's) Mitochondria and Our Mind.Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.Morphological Characterization of the Myenteric Plexus of the Ileum and Distal colon of Dogs Affected by Muscular Dystrophy.Neuroprotective effects of honokiol: from chemistry to medicine.GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment-the involvement of extracellular nucleotides and purinergic signaling.Sterile Inflammation of Brain, due to Activation of Innate Immunity, as a Culprit in Psychiatric Disorders.Activation of A2A Receptor by PDRN Reduces Neuronal Damage and Stimulates WNT/β-CATENIN Driven Neurogenesis in Spinal Cord Injury.Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis.Haploinsufficient TNAP Mice Display Decreased Extracellular ATP Levels and Expression of Pannexin-1 Channels.Is Adenosine Action Common Ground for NREM Sleep, Torpor, and Other Hypometabolic States?Stimulation-induced increases in cerebral blood flow and local capillary vasoconstriction depend on conducted vascular responses
P2860
Q26771359-1F5B7BBD-289B-4FAD-8AA3-4F075DAD7A93Q28817736-1D50FA21-C020-4D4F-B4D0-773CE396BDC0Q30811097-ADB1813A-4DBE-4CED-AD5C-8068927D981AQ36844881-1A6D5845-D871-4992-B846-09ADD89A0DBCQ37141982-D5062901-B83E-4AC6-9C7C-480CAB200DA1Q38358456-6CDAC37C-1951-49E4-8D14-2DE94CB5178BQ38653049-B885662D-E364-4B76-8F68-65FCFAAE5918Q38662497-9F9C7121-19FB-4E41-BDD6-BFAE22F7DD0AQ38703135-66940376-150F-47FA-BA2F-6D3A9B813E46Q38885851-C4453223-641F-453A-9A03-59BFE3E2FEBBQ39967207-D84473CE-13DB-415E-B728-650BC18E0C82Q41334028-BE592E84-F52B-420A-A365-37305428A32BQ41361968-677B5BC4-C4BF-4EF5-8DAB-1819FBC44C63Q41916385-D8796F7F-FA07-407E-867A-F2697DA16B7EQ42367885-856AD8AD-CEFD-40BA-B395-E6B66F9CA69DQ42377179-6F0218EF-E7FD-45F5-A1F4-53BF9D611BA8Q47095076-D061E71A-592E-43B3-B3E8-7F4F418967FEQ47616363-C688FA0C-C413-46CA-BE9B-0AF91FDBF034Q47838941-CEBFBD90-CB2E-443A-A675-66B24E506004Q48144419-12C0FA8A-1FB7-4C77-9ED1-89B144E49F82Q48150702-8FE3EA4B-E840-4B24-8AE5-413BEF1CD36AQ52150610-7E6DC66C-63FF-43C9-A575-1209FA887455Q52647873-D3A76AE7-C33B-485B-B3DD-6C73532FBC45Q55069783-B145622B-BD67-417A-BC3B-B15431432A0BQ55262715-AD8BB520-F993-460A-B284-B4FA365D7041Q55266660-AC404BF4-9902-4DA1-934F-8A67ABC505E8Q55313072-60B77284-D8ED-4230-B3D1-70E19342DF5AQ55447423-701BE647-F5AC-4704-9377-42665A4C8928Q56384396-47C42D01-3E23-4132-BEFC-9B5C56D48A5FQ58049060-B56A3F7C-16DA-4073-BA9F-A4FF4AC791F6
P2860
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
An introduction to the roles o ...... otection and neuroregeneration
@ast
An introduction to the roles o ...... otection and neuroregeneration
@en
An introduction to the roles o ...... otection and neuroregeneration
@nl
type
label
An introduction to the roles o ...... otection and neuroregeneration
@ast
An introduction to the roles o ...... otection and neuroregeneration
@en
An introduction to the roles o ...... otection and neuroregeneration
@nl
prefLabel
An introduction to the roles o ...... otection and neuroregeneration
@ast
An introduction to the roles o ...... otection and neuroregeneration
@en
An introduction to the roles o ...... otection and neuroregeneration
@nl
P1433
P1476
An introduction to the roles o ...... otection and neuroregeneration
@en
P356
10.1016/J.NEUROPHARM.2015.05.031
P407
P577
2016-05-01T00:00:00Z